Veterinary

IDEXX Laboratories Enhances Veterinary Offerings with CoVetAI Acquisition

IDEXX Laboratories, Inc. (NASDAQ: IDXX) has acquired CoVetAI, a developer of artificial intelligence solutions for veterinary workflows. This acquisition is aimed at enhancing IDEXX's offerings in veterinary practice management by leveraging AI to streamline workflows and improve patient outcomes. The acquisition will allow IDEXX to integrate CoVetAI's technology into its existing product suite, thereby advancing data analytics capabilities in the veterinary sector. Key individuals involved include Jay Mazelsky, CEO of IDEXX, and Dr. Jane Smith, Co-Founder of CoVetAI. The deal is significant as it positions IDEXX to lead in the integration of AI within veterinary care.